echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: Analysis of Risk Factors for Cerebral Hemorrhage in Patients with Atrial Fibrillation Stroke Using Non-Vitamin K Antagonist Oral Anticoagulants

    Stroke: Analysis of Risk Factors for Cerebral Hemorrhage in Patients with Atrial Fibrillation Stroke Using Non-Vitamin K Antagonist Oral Anticoagulants

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The results of clinical trials for stroke prevention in patients with atrial fibrillation consistently show that taking warfarin or non-vitamin K antagonist oral anticoagulants (NOAC) can achieve clinical benefits.


    Stroke prevention

    Recently, the medsci.


    medsci.


    The cases in this study were consecutive patients with atrial fibrillation who developed ICH during NOAC treatment.


    The study included 419 patients (mean age of 78.


    It can be seen that some risk factors are related to the occurrence of ICH in patients taking NOAC to prevent stroke, but the HAS-BLED and CHA2DS2-VASc scores are not related to them .


    Some risk factors are related to the occurrence of ICH in patients taking NOAC to prevent stroke, but HAS-BLED and CHA2DS2-VASc scores are not related to them

    Original source:

    Original source:

    Maurizio Paciaroni.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.